Queensland Children's Hospital
South Brisbane QLD 4101
1 studies enrolling now · 27 studies all time
What they study most
Acute Respiratory Distress Syndrome, Adenovirus Infection, Angelman Syndrome, Autism Spectrum Disorder, Autosomal Recessive Hypophosphatemic Rickets, BK Virus Infection, Cardiac Arrest, Cardiopulmonary Arrest, Childhood Solid Tumor, Congenital Heart Disease, Cystic Fibrosis, Cytomegalovirus Infections
Studies at this site
- Quality of Pediatric Resuscitation in a Multicenter Collaborative — Recruiting now
- Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults — Recruiting now
- A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension — Running, not enrolling
- A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
- ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) — Running, not enrolling
- Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) — Completed
- Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age — Running, not enrolling
- Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy — Completed
- Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older — Completed
- A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome — Completed
- Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF) — Completed
- Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
- Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older — Completed
- The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency — Running, not enrolling
- Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects — Completed
- Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder — Completed
- A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation — Completed
- A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
- A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma — Completed
- A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
- Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant — Stopped early
- COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors — Completed
- Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
- A Study Evaluating the Long-term Safety of VX-445 Combination Therapy — Completed
- Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years — Completed
- Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age — Completed
- A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed